CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)
$31.47 0 (0%)
Analysed CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) News Sources
GlobeFlex Exits NCR Atleos After Brink’s Buyout Deal
20-05-2026
fool.com
Catalyst (CPRX) Up 0.6% Since Last Earnings Report: Can It Continue?
10-06-2026
yahoo.com
Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
30-06-2026
yahoo.com
Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®
01-07-2026
yahoo.com
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data
02-07-2026
yahoo.com
Solaris Energy Infrastructure Set to Join S&P SmallCap 600
09-07-2026
yahoo.com
SEI Stock Jumps 5% After-Hours As S&P 600 Inclusion Sparks Buying
10-07-2026
stocktwits.com
Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger
10-07-2026
marketbeat.com
Sector Update: Energy Stocks Advance Pre-Bell Friday
10-07-2026
yahoo.com
Why Solaris Energy Infrastructure (SEI) Stock Is Up Today
10-07-2026
yahoo.com
What is the current price of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The current price of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is $31.47.
CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) since the previous trading day is $0.
CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The most recent average sentiment score for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The most recent sentiment for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is .
SEC-8K** Filing Available For CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.